Human monocyte-derived dendritic cells are a source of several complement proteins.

Area of Science:

• Immunology
• Cell Biology
• Complement System

Background:

• Dendritic cells (DCs) play a crucial role in initiating adaptive immune responses.
• The local production of complement components by DCs and its functional significance remain largely unexplored.
• Complement system proteins are vital for immune cell function and pathogen clearance.

Purpose of the Study:

• To investigate whether human dendritic cells (DCs) synthesize complement proteins.
• To determine the range of complement components produced by DCs.
• To explore the regulation of complement production by DCs in response to inflammatory stimuli.

Main Methods:

• Reverse transcriptase polymerase chain reaction (RT-PCR) was employed to assess mRNA expression of complement proteins in DCs.
• Western blot analysis was utilized to confirm the production of complement proteins by DCs.
• Dendritic cells were treated with lipopolysaccharide (LPS), interleukin-1 (IL-1), or dexamethasone to evaluate regulatory effects.

Main Results:

• Human DCs were found to produce complement components including C3, C5, C9, Factor I, Factor H, Factor B, Factor D, and properdin at levels comparable to macrophages.
• Lipopolysaccharide (LPS) treatment upregulated C3 and Factor I mRNA expression while downregulating C5 mRNA.
• Interleukin-1 (IL-1) and dexamethasone treatments induced a modest increase in C3 mRNA levels but did not significantly affect other complement component mRNAs.

Conclusions:

• Dendritic cells (DCs) represent a significant extrahepatic source of various soluble complement proteins.
• The synthesis of complement proteins by DCs is subject to regulation by inflammatory signals.
• These findings highlight a novel role for DCs in the complement system and immune regulation.